Published in Mol Cell Biol on April 01, 1989
A retinoic acid-responsive element is present in the 5' flanking region of the laminin B1 gene. Proc Natl Acad Sci U S A (1989) 2.32
The cellular transcription factor CREB corresponds to activating transcription factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43. Mol Cell Biol (1990) 1.74
Different binding specificities and transactivation of variant CRE's by CREB complexes. Nucleic Acids Res (1994) 1.64
Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol (1997) 1.32
Cyclic AMP response element-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter. Mol Cell Biol (1992) 1.29
GATA factors and androgen receptor collaborate to transcriptionally activate the Rhox5 homeobox gene in Sertoli cells. Mol Cell Biol (2008) 1.21
E1A dependent up-regulation of c-jun/AP-1 activity. Nucleic Acids Res (1991) 1.11
Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells. Mol Cell Biol (1992) 1.08
PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element. J Virol (1991) 1.04
AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells. Mol Cell Biol (1994) 0.97
Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation. Mol Cell Biol (1990) 0.95
In vitro analysis of the tissue plasminogen activator promoter reveals a GC box-binding activity present in murine brain but undetectable in kidney and liver. Mol Cell Biol (1991) 0.89
Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells. Proc Natl Acad Sci U S A (1992) 0.88
Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro. Nucleic Acids Res (1997) 0.87
Regulation of Cl- transport in T84 cell clones expressing a mutant regulatory subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1990) 0.87
The promoter of the human parathyroid hormone gene contains a functional cyclic AMP-response element. Nucleic Acids Res (1990) 0.78
Retinoids regulate human amniotic tissue-type plasminogen activator gene by a two-step mechanism. J Cell Mol Med (2009) 0.78
Stimulation of tissue plasminogen activator production by retinoic acid: synergistic effect on protein kinase C-mediated activation. Blood (1992) 0.76
Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies. J Bioenerg Biomembr (1997) 0.76
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1989) 0.75
Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid. Biochem J (1998) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem (1981) 49.46
Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA (1985) 40.01
Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates. Nucleic Acids Res (1979) 31.23
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell (1977) 18.95
Analysis of transcriptional regulatory signals of the HSV thymidine kinase gene: identification of an upstream control region. Cell (1981) 12.73
Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc Natl Acad Sci U S A (1986) 10.41
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell (1987) 10.22
A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (1988) 9.07
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J Mol Appl Genet (1983) 8.94
Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature (1987) 8.93
Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell (1987) 7.75
HMG CoA reductase: a negatively regulated gene with unusual promoter and 5' untranslated regions. Cell (1984) 7.66
Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell (1987) 7.51
The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell (1978) 6.82
Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell (1980) 6.72
Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc Natl Acad Sci U S A (1984) 6.48
Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci U S A (1973) 5.20
Identification of a second human retinoic acid receptor. Nature (1988) 5.11
Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell (1986) 4.82
Teratocarcinomas and mammalian embryogenesis. Science (1980) 4.72
cis and trans activation of globin gene transcription in transient assays. Proc Natl Acad Sci U S A (1983) 4.41
Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc Natl Acad Sci U S A (1985) 4.08
Promoter region of the human Harvey ras proto-oncogene: similarity to the EGF receptor proto-oncogene promoter. Science (1985) 3.59
The human tissue plasminogen activator gene. J Biol Chem (1986) 3.35
Multiple transcription start sites, DNase I-hypersensitive sites, and an opposite-strand exon in the 5' region of the CHO dhfr gene. Mol Cell Biol (1986) 2.82
Duplications of a mutated simian virus 40 enhancer restore its activity. Nature (1985) 2.75
Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells. Nature (1987) 2.65
DNA fragments from F9 PyEC mutants increase expression of heterologous genes in transfected F9 cells. Cell (1983) 2.64
Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm. Nature (1981) 2.62
Heterogeneity at the 5' termini of mouse dihydrofolate reductase mRNAs. Evidence for multiple promoter regions. J Biol Chem (1985) 2.29
Early retinoic acid-induced F9 teratocarcinoma stem cell gene ERA-1: alternate splicing creates transcripts for a homeobox-containing protein and one lacking the homeobox. Mol Cell Biol (1988) 2.10
Tissue-specific activation of a cloned alpha-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line. Nature (1984) 2.02
An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell (1987) 1.96
Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.90
Identification of basal and cyclic AMP regulatory elements in the promoter of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol (1988) 1.89
Mouse teratocarcinoma cells: prospects for the study of embryogenesis and neoplasia. Cell (1981) 1.89
Origin and differentiation of extraembryonic tissues in the mouse. Int Rev Exp Pathol (1983) 1.88
The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc Natl Acad Sci U S A (1988) 1.68
A common trans-acting factor is involved in transcriptional regulation of neurotransmitter genes by cyclic AMP. Mol Cell Biol (1988) 1.61
A method for increasing the sensitivity of chloramphenicol acetyltransferase assays in extracts of transfected cultured cells. Anal Biochem (1987) 1.59
The production of distinct forms of plasminogen activator by mouse embryonic cells. Dev Biol (1982) 1.48
Conservation of promoter sequence but not complex intron splicing pattern in human and hamster genes for 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mol Cell Biol (1987) 1.45
Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. J Biol Chem (1988) 1.31
Apolipoprotein II messenger RNA. Transcriptional and splicing heterogeneity yields six 5'-untranslated leader sequences. J Biol Chem (1984) 1.29
Tumor viruses and early mouse embryos. Biochim Biophys Acta (1982) 1.27
Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells. Proc Natl Acad Sci U S A (1988) 1.26
Regulated expression of an introduced MHC H-2K bm1 gene in murine embryonal carcinoma cells. Nature (1984) 1.22
Molecular cloning of the murine adenosine deaminase gene from a genetically enriched source: identification and characterization of the promoter region. Mol Cell Biol (1986) 1.21
SV40 enhancer activation during retinoic acid-induced differentiation of F9 embryonal carcinoma cells. EMBO J (1985) 1.18
A factor discriminating between the wild-type and a mutant polyomavirus enhancer. Nature (1987) 1.16
Characterization of the mouse SPARC/osteonectin gene. Intron/exon organization and an unusual promoter region. J Biol Chem (1988) 1.15
High molecular weight extracellular proteins synthesized by endoderm cells derived from mouse teratocarcinoma cells and normal extraembryonic membranes. Dev Biol (1980) 1.11
The nature of the host range restriction of SV40 and polyoma viruses in embryonal carcinoma cells. Curr Top Microbiol Immunol (1982) 1.07
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region. J Biol Chem (1985) 1.07
Tissue plasminogen activator mRNA in murine tissues. FEBS Lett (1988) 1.01
Anti-sense inhibition of tissue plasminogen activator production in differentiated F9 teratocarcinoma cells. Dev Biol (1988) 0.83
The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell (1978) 6.82
Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell (1980) 6.72
Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol Cell Biol (1984) 4.76
Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med (1998) 4.09
Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature (1995) 3.06
Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell (1976) 2.87
The production of superoxide anion radicals in the reaction of reduced flavins and flavoproteins with molecular oxygen. Biochem Biophys Res Commun (1969) 2.72
Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell (1997) 2.68
Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins. J Biol Chem (1976) 2.56
Determination of dissociation constants and specific rate constants of enzyme-substrate (or protein-ligand) interactions from rapid reaction kinetic data. J Biol Chem (1975) 2.39
Coordinate initiation of Drosophila development by regulated polyadenylation of maternal messenger RNAs. Science (1994) 2.25
Nanos and pumilio establish embryonic polarity in Drosophila by promoting posterior deadenylation of hunchback mRNA. Development (1997) 2.19
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol (2002) 2.06
An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci (1997) 2.03
Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther (1999) 2.01
Regulated polyadenylation controls mRNA translation during meiotic maturation of mouse oocytes. Genes Dev (1989) 1.95
Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell (1975) 1.93
Mouse teratocarcinoma cells: prospects for the study of embryogenesis and neoplasia. Cell (1981) 1.89
Transient translational silencing by reversible mRNA deadenylation. Cell (1992) 1.88
Assaying the polyadenylation state of mRNAs. Methods (1999) 1.87
Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem (1998) 1.80
Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA. Genes Dev (1987) 1.74
Mapping of Drosophila mutations using site-specific male recombination. Genetics (1998) 1.67
Analysis of poly(A) tail lengths by PCR: the PAT assay. Methods Mol Biol (1999) 1.65
A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer (1980) 1.63
Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci (1996) 1.59
Rapid and sensitive analysis of mRNA polyadenylation states by PCR. PCR Methods Appl (1995) 1.56
The production of distinct forms of plasminogen activator by mouse embryonic cells. Dev Biol (1982) 1.48
Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol (2000) 1.43
Evolutionary conservation of sequence elements controlling cytoplasmic polyadenylylation. Proc Natl Acad Sci U S A (1996) 1.35
Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. Biochemistry (1986) 1.34
Neuronal cell death and tPA. Nature (1996) 1.33
Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc Natl Acad Sci U S A (1999) 1.33
The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid. Dev Biol (1979) 1.31
Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. J Biol Chem (1988) 1.31
Isolation of novel murine maternal mRNAs regulated by cytoplasmic polyadenylation. Genes Dev (1992) 1.31
Mutations that perturb poly(A)-dependent maternal mRNA activation block the initiation of development. Development (1996) 1.30
Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci U S A (1997) 1.26
Fibrin overlay methods for the detection of single transformed cells and colonies of transformed cells. Cell (1975) 1.25
Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci (1999) 1.20
Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci U S A (1995) 1.17
Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: plasminogen activator production. Cancer Res (1976) 1.14
The mechanism of action of the flavoprotein melilotate hydroxylase. J Biol Chem (1973) 1.13
Cortex, a Drosophila gene required to complete oocyte meiosis, is a member of the Cdc20/fizzy protein family. Genesis (2001) 1.12
Structural components and characteristics of Reichert's membrane, an extra-embryonic basement membrane. J Biol Chem (1981) 1.12
The mouse tissue plasminogen activator gene 5' flanking region directs appropriate expression in development and a seizure-enhanced response in the CNS. Development (1994) 1.11
Obligatory separation of hormone binding and biological response curves in systems dependent upon secondary mediators of hormone action. Proc Natl Acad Sci U S A (1981) 1.08
The purification and properties of the flavoprotein melilotate hydroxylase. J Biol Chem (1973) 1.07
Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther (2001) 1.05
Stress-induced spine loss in the medial amygdala is mediated by tissue-plasminogen activator. Neuroscience (2006) 1.05
Tissue plasminogen activator mRNA in murine tissues. FEBS Lett (1988) 1.01
Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes. Arch Biochem Biophys (2001) 0.99
Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J Neurochem (1997) 0.99
Studies on the effect of retinoids on the differentiation of teratocarcinoma stem cells in vitro and in vivo. Dev Biol (1980) 0.99
Maintenance and use of F9 teratocarcinoma cells. Methods Enzymol (1990) 0.97
Expression of the murine apolipoprotein E gene is coupled to the differentiated state of F9 embryonal carcinoma cells. Proc Natl Acad Sci U S A (1987) 0.97
Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation. Mol Cell Biol (1990) 0.95
Two-stage hormonal control of type IV collagen mRNA levels during differentiation of F9 teratocarcinoma cells. Dev Biol (1985) 0.93
The only function of Grauzone required for Drosophila oocyte meiosis is transcriptional activation of the cortex gene. Genetics (2000) 0.92
Hormone binding and coupled response relationships in systems dependent on the generation of secondary mediators. Mol Endocrinol (1987) 0.92
Plasminogen activator in the rat ovary. Production and gonadotropin regulation of the enzyme in granulosa and thecal cells. J Biol Chem (1985) 0.92
Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator. J Cell Biol (1987) 0.92
Corticosteroid-potentiated vascular responses of the equine digit: a possible pharmacologic basis for laminitis. Am J Vet Res (1979) 0.91
Antigenicity of venous allografts. Ann Surg (1979) 0.91
Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury. Neuroscience (2003) 0.90
Fibrinogen, a possible key player in Alzheimer's disease. J Thromb Haemost (2009) 0.90
In vitro analysis of the tissue plasminogen activator promoter reveals a GC box-binding activity present in murine brain but undetectable in kidney and liver. Mol Cell Biol (1991) 0.89
Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes. J Neurosci (1999) 0.88
Completion of meiosis in Drosophila oocytes requires transcriptional control by grauzone, a new zinc finger protein. Development (2000) 0.87
Cytoplasmic polyadenylation of Toll mRNA is required for dorsal-ventral patterning in Drosophila embryogenesis. Development (1998) 0.85
The GluK4 kainate receptor subunit regulates memory, mood, and excitotoxic neurodegeneration. Neuroscience (2013) 0.85
Expression of SPARC/osteonectin transcript in murine embryos and gonads. Differentiation (1988) 0.85
A cell culture assay for follicle-stimulating hormone. J Biol Chem (1978) 0.84
Chromosomal assignments of genes for tissue plasminogen activator and urokinase in mouse. Somat Cell Mol Genet (1987) 0.84
Studies on the hormonal regulation of plasminogen activator production in the rat ovary. Endocrinology (1986) 0.84
Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain. J Thromb Haemost (2014) 0.84
Anti-sense inhibition of tissue plasminogen activator production in differentiated F9 teratocarcinoma cells. Dev Biol (1988) 0.83
A plasminogen activator is induced during goldfish optic nerve regeneration. EMBO J (1990) 0.83
Hormonal regulation of tissue plasminogen activator secretion and mRNA levels in rat granulosa cells. J Biol Chem (1987) 0.81
Structural domains of human tissue-type plasminogen activator that confer stimulation by heparin. J Biol Chem (1989) 0.81
Detection of an adenovirus E1A-like activity in mammalian cells. Curr Top Microbiol Immunol (1984) 0.81
Preimplantation mouse embryos express a cell surface receptor for tissue-plasminogen activator. Development (1993) 0.81
Isolation and characterization of two novel, cytoplasmically polyadenylated, oocyte-specific, mouse maternal RNAs. Dev Biol (1996) 0.81
Kinetic and mechanistic studies on the reaction of melilotate hydroxylase with deuterated melilotate. Biochemistry (1975) 0.80
Tissue plasminogen activator in the bed nucleus of stria terminalis regulates acoustic startle. Neuroscience (2005) 0.79
Microinjecting antisense sequences into oocytes. Methods Enzymol (1993) 0.79
Regulated localization confers multiple functions on the protease urokinase plasminogen activator. J Cell Physiol (1997) 0.79
Expression of a secreted transplantation antigen gene during murine embryogenesis. Mol Cell Biol (1986) 0.79
Creating maternal effect mutations in transgenic mice: antisense inhibition of an oocyte gene product. Dev Biol (1993) 0.78
A teratocarcinoma-derived endoderm stem cell line (1H5) that can differentiate into extra-embryonic endoderm cell types. Differentiation (1985) 0.78
Removal of tissue plasminogen activator does not protect against neuronal degeneration in the cerebellum of the weaver mouse. Brain Res (1997) 0.77
Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by tissue plasminogen activator. J Biol Chem (1989) 0.76
Oocyte selection of mutations affecting cytoplasmic polyadenylation of maternal mRNAs. Mol Reprod Dev (1997) 0.76